-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCKET PHARMACEUTICALS, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $7 FROM $12

Reuters·08/11/2026 03:32:43

Please log in to view news